Bone Marrow TransplantationHematologyBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisHematologic NeoplasmsCombined Modality TherapyRecurrenceBone Marrow ExaminationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraMice, Inbred C57BLTreatment OutcomeLeukemia, Myeloid, AcuteTime FactorsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHematologic DiseasesImmunosuppressive AgentsGraft RejectionHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidLymphoma, Non-HodgkinAcute DiseaseImmunosuppressionRetrospective StudiesLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionHeart TransplantationSurvival AnalysisMyelodysplastic SyndromesSevere Combined ImmunodeficiencyChimeraT-LymphocytesColony-Forming Units AssayHLA AntigensBlood Cell CountLeukocyte CountLung TransplantationActuarial AnalysisCyclosporineBone DensityAntineoplastic Combined Chemotherapy ProtocolsLymphocyte TransfusionPancytopeniaFollow-Up StudiesHematologic TestsNuclear FamilyCarmustineSurvival RateOrgan TransplantationCell DifferentiationGraft vs Tumor EffectFlow CytometrySpleenGraft vs Leukemia EffectCytarabineCytomegalovirus InfectionsDisease-Free SurvivalBone ResorptionGranulocyte Colony-Stimulating FactorLymphomaMelphalanMice, Inbred BALB CMultiple MyelomaEtoposidePrognosisHodgkin DiseaseCells, CulturedFatal OutcomePlatelet CountImmunophenotypingAntigens, CD34